All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Controversy session

Stay at the bench or move to the bedside: What is the role for neoadjuvant therapy in melanoma today?

Date
Sun, 19.09.2021
Time
13:30 - 14:05
Location
Channel 6
Chairs
  • Omid Hamid (Los Angeles, CA, United States of America)
Controversy session

Introduction by the chair

Speakers
  • Omid Hamid (Los Angeles, CA, United States of America)
Lecture Time
13:30 - 13:33
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
13:30 - 14:05
Controversy session

Polling 1 (led by chair)

Speakers
  • Omid Hamid (Los Angeles, CA, United States of America)
Lecture Time
13:33 - 13:34
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
13:30 - 14:05
Controversy session

Yes, ready for primetime in the clinic

Speakers
  • Paolo A. Ascierto (Napoli, Italy)
Lecture Time
13:34 - 13:44
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
13:30 - 14:05
Controversy session

No, appropriate for clinical trial/biomarker work at this time

Speakers
  • Reinhard Dummer (Zurich, Switzerland)
Lecture Time
13:44 - 13:54
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
13:30 - 14:05
Controversy session

Polling 2 (led by chair)

Speakers
  • Omid Hamid (Los Angeles, CA, United States of America)
Lecture Time
13:54 - 13:55
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
13:30 - 14:05
Controversy session

Q&A

Speakers
  • Omid Hamid (Los Angeles, CA, United States of America)
Lecture Time
13:55 - 14:05
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Sun, 19.09.2021
Time
13:30 - 14:05